IL17A and rheumatoid arthritis: In this study, a nomogram model developed from electronic medical record (EMR) data integrates traditional LDL-C with emerging immune biomarkers, Th17 and IL-17, to provide a novel approach for assessing obstructive CAD risk in patients with RA.